HomeCompareBPYUP vs ABBV

BPYUP vs ABBV: Dividend Comparison 2026

BPYUP yields 18.96% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPYUP wins by $40121086.84M in total portfolio value
10 years
BPYUP
BPYUP
● Live price
18.96%
Share price
$25.20
Annual div
$4.78
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40121086.94M
Annual income
$39,718,560,144,858.69
Full BPYUP calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — BPYUP vs ABBV

📍 BPYUP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPYUPABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPYUP + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPYUP pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPYUP
Annual income on $10K today (after 15% tax)
$1,611.22/yr
After 10yr DRIP, annual income (after tax)
$33,760,776,123,129.88/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, BPYUP beats the other by $33,760,776,102,073.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPYUP + ABBV for your $10,000?

BPYUP: 50%ABBV: 50%
100% ABBV50/50100% BPYUP
Portfolio after 10yr
$20060543.52M
Annual income
$19,859,280,084,815.23/yr
Blended yield
99.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

BPYUP
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPYUP buys
0
ABBV buys
0
No recent congressional trades found for BPYUP or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPYUPABBV
Forward yield18.96%3.06%
Annual dividend / share$4.78$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.6%
Portfolio after 10y$40121086.94M$102.3K
Annual income after 10y$39,718,560,144,858.69$24,771.77
Total dividends collected$40094280.29M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BPYUP vs ABBV ($10,000, DRIP)

YearBPYUP PortfolioBPYUP Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$14,491$3,791.11$11,550$430.00+$2.9KBPYUP
2$25,774$10,268.68$13,472$627.96+$12.3KBPYUP
3$61,717$34,138.43$15,906$926.08+$45.8KBPYUP
4$218,832$152,794.76$19,071$1,382.55+$199.8KBPYUP
5$1,246,805$1,012,655.35$23,302$2,095.81+$1.22MBPYUP
6$12,118,488$10,784,406.22$29,150$3,237.93+$12.09MBPYUP
7$208,892,864$195,926,081.95$37,536$5,121.41+$208.86MBPYUP
8$6,536,193,451$6,312,678,086.34$50,079$8,338.38+$6536.14MBPYUP
9$376,193,269,631$369,199,542,638.17$69,753$14,065.80+$376193.20MBPYUP
10$40,121,086,943,363$39,718,560,144,858.69$102,337$24,771.77+$40121086.84MBPYUP

BPYUP vs ABBV: Complete Analysis 2026

BPYUPStock

Brookfield Property REIT Inc. (?BPYU?) is a subsidiary of Brookfield Property Partners L.P., (NASDAQ: BPY; TSX: BPY.UN) (?BPY?) one of the world's premier real estate companies, with approximately $88 billion in total assets. BPYU was created as a public security that is intended to offer economic equivalence to an investment in BPY in the form of a U.S. REIT stock.

Full BPYUP Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this BPYUP vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPYUP vs SCHDBPYUP vs JEPIBPYUP vs OBPYUP vs KOBPYUP vs MAINBPYUP vs JNJBPYUP vs MRKBPYUP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.